✦ LIBER ✦
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)
✍ Scribed by Awada, A.; Bondarenko, I. N.; Bonneterre, J.; Nowara, E.; Ferrero, J. M.; Bakshi, A. V.; Wilke, C.; Piccart, M.
- Book ID
- 125519848
- Publisher
- Oxford University Press
- Year
- 2014
- Tongue
- English
- Weight
- 208 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0923-7534
No coin nor oath required. For personal study only.